Clinical Trial Update: Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating baloxavir marboxil and oseltamivir for severe influenza in immunocompromised patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• Tamiflu (oseltamivir)
• XOFLUZA (baloxavir marboxil)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Influenza | Phase 2 | Status: RECRUITING